By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

InDex Pharmaceuticals AB 

Scheeles väg 2

Stockholm    SE-171 77  Sweden
Phone: 46-8-50884730 Fax: 46-8-50884739


SEARCH JOBS


Key Statistics


Email: info@indexpharmab.com
Ownership: Private

Web Site: InDex Pharmaceuticals AB
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
InDex Pharmaceuticals AB Receives Orphan-Drug Designation For Pediatric Ulcerative Colitis In The U.S. 8/9/2017 10:22:07 AM
InDex Pharmaceuticals AB Gets New Patent Granted In Europe 7/6/2017 6:55:17 AM
InDex Pharmaceuticals AB Enrolls First Patient In The Phase IIb Study CONDUCT With Cobitolimod 6/21/2017 6:29:22 AM
Bulletin From Annual General Meeting In InDex Pharmaceuticals AB 5/31/2017 1:14:37 PM
InDex Pharmaceuticals AB Release: Interim Report January - March 2017 5/30/2017 10:57:43 AM
InDex Pharmaceuticals AB Will Participate In The Digestive Disease Week (DDW) 5/8/2017 11:07:39 AM
Notice Of Annual General Meeting In InDex Pharmaceuticals AB 4/27/2017 1:00:02 PM
InDex Pharmaceuticals AB Publishes Annual Report For 2016 4/27/2017 11:25:40 AM
InDex Pharmaceuticals AB Concludes Well Attended Investigators' Meeting For The Phase IIb Study Conduct 3/22/2017 8:46:23 AM
InDex Pharmaceuticals AB Gets Patent For Additional DIMS Compounds Granted In The U.S. 3/14/2017 8:17:13 AM
1234
//-->